![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1875-6131|2|4|297-308
ISSN: 1568-0142
Source: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol.2, Iss.4, 2003-12, pp. : 297-308
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Immunological Treatment Options for Schizophrenia
Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Update on ocular allergy treatment
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
A review of olopatadine for the treatment of ocular allergy
Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 9, 2004-09 ,pp. :